NovoMed PARTNERS Officially Launches to Build the Next Generation of Transformative Medical Technology Companies

NovoMed PARTNERS Officially Launches to Build the Next Generation of Transformative Medical Technology CompaniesNovoMed PARTNERS, a new healthcare innovation and growth platform founded by a team of trusted medtech entrepreneurs and executive operators, today officially launched its operations.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260723298195/en/ NovoMed PARTNERS at LSI ASIA 2026 in Singapore, from left, Mike Feher, Ramin Mousavi, Natalie Sickler, and Fabian NgoFounded by Ramin Mousavi, former CEO of CathWorks, and an accomplished group of co-founders, Mike Feher, Fabian Ngo, andNatalie Sickler,NovoMed PARTNERS brings together an executive leadership team with decades of experience building category-defining medical technology companies. Together, the founding partners have built and led high-performing organizations that developed transformative technologies, generated industry-leading clinical evidence, commercialized innovative products globally, and completed multiple strategic acquisitions recognized as industry benchmarks.NovoMed PARTNERS was founded to partner with visionary entrepreneurs, investors, strategic partners, physicians, and healthcare innovators to accelerate innovation, build enduring companies, and improve patient lives.“NovoMed PARTNERS was built on a simple belief—that extraordinary companies are created by extraordinary people working with a shared purpose,” said Ramin Mousavi, Founder, Chairman & CEO of NovoMed PARTNERS. “Our mission is to partner with exceptional entrepreneurs, visionary investors, and innovative healthcare companies to accelerate growth, create lasting value, and bring meaningful technologies to patients faster.”A Three-Pillar PlatformNovoMed PARTNERS operates through three complementary business pillars designed to support companies across every stage of their lifecycle.NovoMed Portfolio CompaniesNovoMed Portfolio Companies invests in, builds, and actively supports a focused portfolio of innovative healthcare and medical technology companies, providing strategic leadership, operational expertise, executive talent, commercialization guidance, and governance to accelerate sustainable growth and maximize long-term value creation.NovoMed Advisory ServicesNovoMed Advisory Services provides strategic advisory services to medical technology companies, investors, boards of directors, and private equity firms navigating critical inflection points. Drawing on decades of executive leadership experience, the team advises companies, investors, boards, and private equity firms on corporate strategy, fundraising, commercialization, clinical evidence generation, organizational scaling, leadership development, mergers and acquisitions, value creation, and exit planning.NovoMed StudioNovoMed Studio serves as the firm's collaboration and content engine, bringing together physicians, entrepreneurs, investors, and strategic partners to discuss and debate meaningful unmet clinical needs and breakthrough ideas. Through original content and thought leadership, the Studio connects the global medtech ecosystem while elevating the innovation shaping the future of healthcare.Built by Operators, for OperatorsUnlike traditional investment groups, consulting firms or incubators, NovoMed PARTNERS is built and led by operators who have successfully navigated every stage of the company lifecycle—from concept and product development to global commercialization, organizational scaling, strategic partnerships, and successful acquisitions. The founding team has earned a reputation for assembling exceptional leadership teams, cultivating high-performance cultures, executing complex global growth strategies, generating industry-leading clinical evidence, and creating significant value for patients, physicians, employees, investors, and shareholders.“Our experience has taught us that breakthrough innovation alone is not enough,” Mousavi added. “Building enduring companies requires exceptional leadership, disciplined execution, world-class talent, and an unwavering commitment to patients. That is where NovoMed PARTNERS is uniquely positioned to help.”A Long-Term Commitment to Transformative Healthcare InnovationNovoMed PARTNERS was founded with a long-term vision to become one of the industry's premier company-building platforms, helping shape the future of medical technology through strategic investment, operational excellence, and entrepreneurial partnership.By combining proven operating experience, deep industry relationships, and a passion for innovation, NovoMed PARTNERS aims to become the partner of choice for entrepreneurs, investors, and healthcare companies building transformative businesses that improve patient outcomes worldwide.About NovoMed PARTNERSNovoMed PARTNERS is a healthcare innovation, investment, and advisory platform dedicated to building the next generation of transformative medical technology companies. Through its three integrated pillars—NovoMed Portfolio Companies, NovoMed Advisory Services, and NovoMed Studio—the firm partners with entrepreneurs, investors, physicians, and healthcare organizations to create, scale, and commercialize breakthrough innovations that improve patient care and deliver long-term stakeholder value. For more information, visit our website www.novomedpartners.com and follow us on LinkedIn, X, YouTube, and Instagram @NovoMedPARTNERS. Public RelationsNatalie Sicklermedia@nmpartners.comInvestor RelationsMike Feherinvestor@nmpartners.comView source version on businesswire.com: https://www.businesswire.com/news/home/20260723298195/en/

Raccontata damorningstar.com